Literature DB >> 23995329

Novel techniques for the diagnosis of Ménière's disease.

Christopher H Le1, Anh Q Truong, Rodney C Diaz.   

Abstract

PURPOSE OF REVIEW: This review will consider the newly developed and emerging diagnostic techniques with real or potential clinical application to the diagnosis of Ménière's disease. RECENT
FINDINGS: Several new diagnostic modalities have been introduced, which have the potential to help diagnose endolymphatic hydrops. These include cervical and ocular vestibular evoked myogenic potentials, cochlear hydrops analysis masking procedures, and three-dimensional fluid-attenuated inversion recovery MRI following intratympanic instillation of gadolinium.
SUMMARY: Diagnosis of Ménière's disease has classically been of a clinical rather than a procedural nature. Despite the many recent advances in diagnostic testing which show potential applicability for aiding in diagnosis of Ménière's disease, each has limitations which prevent immediate utility. For now, Ménière's disease remains best diagnosed through the standard American Academy of Otolaryngology - Head and Neck Surgery clinical inclusionary and exclusionary criteria.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23995329     DOI: 10.1097/MOO.0b013e328364869b

Source DB:  PubMed          Journal:  Curr Opin Otolaryngol Head Neck Surg        ISSN: 1068-9508            Impact factor:   2.064


  3 in total

Review 1.  Validity and Reliability of the Diagnostic Tests for Ménière's Disease.

Authors:  Enis Alpin Güneri; Aslı Çakır; Başak Mutlu
Journal:  Turk Arch Otorhinolaryngol       Date:  2016-08-15

2.  A network-based method using a random walk with restart algorithm and screening tests to identify novel genes associated with Menière's disease.

Authors:  Lin Li; YanShu Wang; Lifeng An; XiangYin Kong; Tao Huang
Journal:  PLoS One       Date:  2017-08-07       Impact factor: 3.240

Review 3.  Biomarkers in Vestibular Schwannoma-Associated Hearing Loss.

Authors:  Luis Lassaletta; Miryam Calvino; Jose Manuel Morales-Puebla; Pablo Lapunzina; Lourdes Rodriguez-de la Rosa; Isabel Varela-Nieto; Victor Martinez-Glez
Journal:  Front Neurol       Date:  2019-09-18       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.